Cytek Biosciences (CTKB) Capital Expenditures (QoQ) (2020 - 2026)
Cytek Biosciences (CTKB) Capital Expenditures (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Cytek Biosciences | 610.41 Mn | 536.56 Mn | 28.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.21% |
| Mar 31, 2026 | 173.39% |
| Dec 31, 2025 | -197.08% |
| Sep 30, 2025 | 1,668.56% |
| Jun 30, 2025 | -182.91% |
| Mar 31, 2025 | 200.00% |
| Dec 31, 2024 | 105.13% |
| Sep 30, 2024 | -244.44% |
| Jun 30, 2024 | 85.71% |
| Mar 31, 2024 | 118.24% |
| Dec 31, 2023 | -199.68% |
| Sep 30, 2023 | 2,960.55% |
| Jun 30, 2023 | -178.42% |
| Mar 31, 2023 | -97.87% |
| Dec 31, 2022 | 488.29% |
| Sep 30, 2022 | -40.96% |
| Jun 30, 2022 | 724.56% |
| Mar 31, 2022 | -82.41% |
| Dec 31, 2021 | -52.53% |
| Sep 30, 2021 | 1,696.49% |